/Companies

Inversion Therapeutics

Burlingame, US · Founded 2024 · Delaware corporation

Find your way into Inversion Therapeutics

Sign up to see every warm intro you have to Inversion Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Inversion Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

JA
James A. Wells, Ph.D.Named on SEC filing

Board

SW
Samad Wahid, M.D.Board director
JC
Jeremy Caldwell, Ph.D.Board director
WM
William Michael Kavanaugh, M.D.Board director

Reported raises · per SEC filings

Form D private placements

$6.9M disclosed across 1 round · 2025

▶$6.9MraisedAug 2025 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Samad Wahid, M.D.Director
  • James A. Wells, Ph.D.Executive Officer, Director
  • Jeremy Caldwell, Ph.D.Director
  • William Michael Kavanaugh, M.D.Director
Offering amount
$11.1M
Amount sold
$6.9M
First sale
Jun 2025
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Inversion Therapeutics raised?
Inversion Therapeutics has disclosed $6.9M raised across 1 round.
Where is Inversion Therapeutics headquartered?
Inversion Therapeutics is headquartered in Burlingame, US.